-+ 0.00%
-+ 0.00%
-+ 0.00%

LAKEWOOD-AMEDEX BIOTHERAPEUTICS - BISPHOSPHOCIN NU-3 PHASE 2A TRIAL TOPLINE DATA EXPECTED Q1 2027

Reuters·10/07/2026 12:04:20